Published in Pharm Res on March 18, 2011
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges. Pharmaceuticals (Basel) (2013) 1.21
Nuclease-resistant DNA via high-density packing in polymeric micellar nanoparticle coronas. ACS Nano (2013) 0.93
Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases. Biogerontology (2014) 0.87
Dendrimers for siRNA Delivery. Pharmaceuticals (Basel) (2013) 0.82
Molecular targeting of liposomal nanoparticles to tumor microenvironment. Int J Nanomedicine (2012) 0.82
Design and in vitro evaluation of layer by layer siRNA nanovectors targeting breast tumor initiating cells. PLoS One (2014) 0.80
Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified berberine chloride nanoparticles. Biomed Res Int (2014) 0.77
Bulk and nanoscale polypeptide based polyelectrolyte complexes. Adv Colloid Interface Sci (2016) 0.77
Imaging mRNA expression levels in living cells with PNA·DNA binary FRET probes delivered by cationic shell-crosslinked nanoparticles. Org Biomol Chem (2013) 0.76
Chitosan-Based Nano-Embedded Microparticles: Impact of Nanogel Composition on Physicochemical Properties. Pharmaceutics (2016) 0.75
siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev (2009) 2.21
Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release (2008) 2.15
Thermally triggered intracellular explosion of volume transition nanogels for necrotic cell death. J Control Release (2008) 1.77
All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed Engl (2009) 1.77
Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release (2004) 1.71
siRNA conjugate delivery systems. Bioconjug Chem (2009) 1.69
Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release (2004) 1.59
Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. Nat Mater (2010) 1.50
Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery. Adv Drug Deliv Rev (2009) 1.50
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J Control Release (2006) 1.44
L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial. Endocr J (2016) 1.40
Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials (2009) 1.34
Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J Control Release (2004) 1.34
Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir (2005) 1.32
Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev (2007) 1.28
Biomimicking extracellular matrix: cell adhesive RGD peptide modified electrospun poly(D,L-lactic-co-glycolic acid) nanofiber mesh. Tissue Eng (2006) 1.22
Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release (2007) 1.20
Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging. Biomaterials (2011) 1.18
Heparin-coated gold nanoparticles for liver-specific CT imaging. Chemistry (2009) 1.17
Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast t1- and t2-weighted magnetic resonance imaging. Bioconjug Chem (2010) 1.14
Gas foamed open porous biodegradable polymeric microspheres. Biomaterials (2006) 1.14
Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers. Int J Pharm (2008) 1.13
Hyaluronic acid modified biodegradable scaffolds for cartilage tissue engineering. Biomaterials (2005) 1.11
Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug Chem (2008) 1.11
A family of bioreducible poly(disulfide amine)s for gene delivery. Biomaterials (2009) 1.10
Bioinspired Surface Immobilization of Hyaluronic Acid on Monodisperse Magnetite Nanocrystals for Targeted Cancer Imaging. Adv Mater (2008) 1.09
Bioorthogonal copper-free click chemistry in vivo for tumor-targeted delivery of nanoparticles. Angew Chem Int Ed Engl (2012) 1.09
Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. J Control Release (2002) 1.07
Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis. Bioconjug Chem (2010) 1.07
Nanomaterials for cancer therapy and imaging. Mol Cells (2011) 1.05
Catechol-functionalized chitosan/pluronic hydrogels for tissue adhesives and hemostatic materials. Biomacromolecules (2011) 1.04
PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake. Langmuir (2009) 1.03
Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. J Control Release (2007) 1.02
Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA. Biopolymers (2008) 1.02
Substrate-Independent Layer-by-Layer Assembly by Using Mussel-Adhesive-Inspired Polymers. Adv Mater (2008) 1.02
Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. Pharm Res (2006) 1.01
Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels. Biomaterials (2005) 1.01
Biodegradable PLGA microcarriers for injectable delivery of chondrocytes: effect of surface modification on cell attachment and function. Biotechnol Prog (2004) 1.00
Folate immobilized and PEGylated adenovirus for retargeting to tumor cells. Bioconjug Chem (2006) 1.00
Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA. Mol Pharm (2008) 0.99
Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone. J Control Release (2006) 0.98
Chitosan oligosaccharide-stabilized ferrimagnetic iron oxide nanocubes for magnetically modulated cancer hyperthermia. ACS Nano (2012) 0.98
Immobilization of cell adhesive RGD peptide onto the surface of highly porous biodegradable polymer scaffolds fabricated by a gas foaming/salt leaching method. Biomaterials (2004) 0.98
Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers (2008) 0.98
Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. Biomaterials (2008) 0.97
Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjug Chem (2006) 0.97
Synthesis, characterization, antitumor activity of pluronic mimicking copolymer micelles conjugated with doxorubicin via acid-cleavable linkage. Bioconjug Chem (2007) 0.97
Development of dual scale scaffolds via direct polymer melt deposition and electrospinning for applications in tissue regeneration. Acta Biomater (2008) 0.97
Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method. Biomaterials (2003) 0.96
A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles. J Control Release (2003) 0.96
Synthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell death. Biomaterials (2008) 0.95
Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal. Bioconjug Chem (2008) 0.95
Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide. Bioconjug Chem (2003) 0.94
Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight. J Control Release (2010) 0.94
N-terminal site-specific mono-PEGylation of epidermal growth factor. Pharm Res (2003) 0.94
Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction. J Control Release (2009) 0.94
Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method. Eur J Pharm Biopharm (2007) 0.94
LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI. Bioconjug Chem (2008) 0.93
Stabilization of recombinant interferon-alpha by pegylation for encapsulation in PLGA microspheres. Int J Pharm (2003) 0.93
Macroporous and nanofibrous hyaluronic acid/collagen hybrid scaffold fabricated by concurrent electrospinning and deposition/leaching of salt particles. Acta Biomater (2008) 0.92
PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. J Control Release (2002) 0.92
Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. J Biomed Mater Res A (2006) 0.92
Facile synthetic route for surface-functionalized magnetic nanoparticles: cell labeling and magnetic resonance imaging studies. ACS Nano (2011) 0.91
Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug. J Control Release (2010) 0.91
pH-responsive polymeric micelle based on PEG-poly(β-amino ester)/(amido amine) as intelligent vehicle for magnetic resonance imaging in detection of cerebral ischemic area. J Control Release (2010) 0.91
Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice. Bioconjug Chem (2013) 0.90
Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres. Int J Pharm (2004) 0.90
RGD targeting hyaluronic acid coating system for PEI-PBLG polycation gene carriers. J Control Release (2011) 0.90
In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles. Bioconjug Chem (2011) 0.90
Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehicles. Pharm Res (2011) 0.89
Receptor-mediated gene delivery into antigen presenting cells using mannosylated chitosan/DNA nanoparticles. J Nanosci Nanotechnol (2006) 0.89
Protein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumor-targeting of siRNA. Biomaterials (2013) 0.89
Thermo-sensitive and biodegradable hydrogels based on stereocomplexed Pluronic multi-block copolymers for controlled protein delivery. J Control Release (2007) 0.89
Thermal and mechanical characteristics of poly(L-lactic acid) nanocomposite scaffold. Biomaterials (2003) 0.89
Temperature-sensitive pluronic/poly(ethylenimine) nanocapsules for thermally triggered disruption of intracellular endosomal compartment. Biomacromolecules (2006) 0.88
Antifibrotic effect of MMP13-encoding plasmid DNA delivered using polyethylenimine shielded with hyaluronic acid. Mol Ther (2010) 0.88
Clustered magnetite nanocrystals cross-linked with PEI for efficient siRNA delivery. Biomacromolecules (2010) 0.88
Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. Biochem Biophys Res Commun (2007) 0.88
G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method. Int J Pharm (2006) 0.88
Controlled protein release from electrospun biodegradable fiber mesh composed of poly(epsilon-caprolactone) and poly(ethylene oxide). Int J Pharm (2007) 0.88
In vivo tumor targeting of ODN-PEG-folic acid/PEI polyelectrolyte complex micelles. J Biomater Sci Polym Ed (2005) 0.88
Nanoparticulate carrier containing water-insoluble iodinated oil as a multifunctional contrast agent for computed tomography imaging. Biomaterials (2007) 0.88
Reducible poly(amido ethylenimine)-based gene delivery system for improved nucleus trafficking of plasmid DNA. Bioconjug Chem (2010) 0.87
Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia. Pharm Res (2010) 0.87
Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain. J Gene Med (2009) 0.87
Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice. J Control Release (2013) 0.87
Synthesis and characterization of elastic PLGA/PCL/PLGA tri-block copolymers. J Biomater Sci Polym Ed (2002) 0.87
Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition. Bioconjug Chem (2007) 0.86
Folate receptor-mediated gene delivery using folate-poly(ethylene glycol)-poly(L-lysine) conjugate. Macromol Biosci (2005) 0.86
High-strength carbon nanotube fibers fabricated by infiltration and curing of mussel-inspired catecholamine polymer. Adv Mater (2011) 0.86
Poly(L-lysine)-g-poly(D,L-lactic-co-glycolic acid) micelles for low cytotoxic biodegradable gene delivery carriers. J Control Release (2002) 0.86
Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres. Biomaterials (2002) 0.86
Anti-GAD antibody targeted non-viral gene delivery to islet beta cells. J Control Release (2005) 0.86
Heparin immobilized gold nanoparticles for targeted detection and apoptotic death of metastatic cancer cells. Biomaterials (2010) 0.86